Black Rock Inc. Ardelyx, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding ARDX
# of Institutions
235Shares Held
164MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$105 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$63.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$47 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$42.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X08.38MShares$35.3 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $651M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...